• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.82% Nasdaq Down1.23%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    173.26 Down 2.02(1.15%) 1:00PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 2,233,733   1,551,346   1,134,114  
    Cost of Revenue173,862  177,556  72,837  
    Gross Profit 2,059,871   1,373,790   1,061,277  
    Operating Expenses
    Research Development513,782  317,093  222,732  
    Selling General and Administrative630,209  489,720  384,678  
    Non Recurring47,174  38,550  49,112  
    Others -  417  417  
    Total Operating Expenses -  845,780  656,939  
    Operating Income or Loss 868,706   528,010   404,338  
    Income from Continuing Operations
    Total Other Income/Expenses Net6,383  2,371  630  
    Earnings Before Interest And Taxes875,089  530,381  404,968  
    Interest Expense2,982  4,112  7,402  
    Income Before Tax872,107  526,269  397,566  
    Income Tax Expense215,195  273,374  142,744  
    Minority Interest -   -   -  
    Net Income From Continuing Ops656,912  252,895  254,822  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 656,912   252,895   254,822  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 656,912   252,895   254,822  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.